Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2018

03.04.2017 | Original Research

Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre

verfasst von: Santosh Kumar Singh, Rajnish Talwar, Narayanan Kannan, Arvind Kumar Tyagi, Pradeep Jaiswal, Adarsh Kumar

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

India has high incidence of gallbladder carcinoma with regional variation in incidence, the highest in Northern India. This study examines the patterns of presentation, treatment strategies, and survival rate of all patients with gallbladder cancer (GBC) evaluated at our tertiary academic hospital over a period of 2 years.

Methods

All patients presented to our institute with established tissue diagnosis of carcinoma gallbladder were accrued in our study over a time period of 2 years. Presentation, treatment modalities, and survival rates were analyzed.

Results

One hundred six patients were included: 80 females and 26 males (F: M = 3:1). Median age was 60 years. Eighty patients (75%) had gallstones and 20 patients (21%) had typical history of chronic cholecystitis. The common symptom and sign at presentation were pain in the right upper abdomen (81%) and lump abdomen (49%), respectively. Overall resectability rate was 19.8% (21/106). Eighty-five patients were unresectable or metastatic and treated with palliative intent. Stagewise distribution at diagnosis was stage I (0%), stage II (4%), stage IIIA (10%), stage IIIB (8%), stage IVA (17%), and stage IVB (61%). Estimated 1-year survival for stages II, IIIA, IIIB, IVA, and IVB was 100, 76, 47.4, 26, and 10.6%, respectively. Significant difference in OS was observed among different stages of GBC (p value <0.001).

Conclusion

If proper investigations are done, radical surgery including multi-organ resection can be curative with acceptable morbidity and mortality. Stage at presentation and ability to perform curative resection are the most important prognostic factors predicting survival. Palliative chemotherapy should be considered for metastatic GBC.
Literatur
1.
Zurück zum Zitat Indian Council of Medical Research. National cancer registry programme. Biennial report 1988–89. An epidemiological study. New Delhi: Indian Council of Medical Research; 1992. p. 14–5. Indian Council of Medical Research. National cancer registry programme. Biennial report 1988–89. An epidemiological study. New Delhi: Indian Council of Medical Research; 1992. p. 14–5.
2.
Zurück zum Zitat Dixon E, Vollmer Jr CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241:385–94.CrossRefPubMedPubMedCentral Dixon E, Vollmer Jr CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241:385–94.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557–69.CrossRefPubMedPubMedCentral Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557–69.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer: implications for staging and management. Ann Surg. 1996;224:639–46.CrossRefPubMedPubMedCentral Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer: implications for staging and management. Ann Surg. 1996;224:639–46.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Tyagi BB, Manoharan N, Raina V. Risk factors for gallbladder cancer: a population based case-control study in Delhi. Indian J Med Paediatr Oncol. 2008;29:16–26.CrossRef Tyagi BB, Manoharan N, Raina V. Risk factors for gallbladder cancer: a population based case-control study in Delhi. Indian J Med Paediatr Oncol. 2008;29:16–26.CrossRef
6.
Zurück zum Zitat Matsukura N, Yokomuro S, Yamada S, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res. 2002;93:842.CrossRefPubMedPubMedCentral Matsukura N, Yokomuro S, Yamada S, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res. 2002;93:842.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Kondo S, Nimura Y, Kamiya J, et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbeck's Arch Surg. 2002;387:222–8.CrossRef Kondo S, Nimura Y, Kamiya J, et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbeck's Arch Surg. 2002;387:222–8.CrossRef
8.
Zurück zum Zitat Hueman MT, Vollmer Jr CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101–15.CrossRefPubMed Hueman MT, Vollmer Jr CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101–15.CrossRefPubMed
9.
Zurück zum Zitat Pitt HA, Nakeeb A. Operative approach to gallbladder cancer. Curr Gastroenterol Rep. 2006;8:161–7.CrossRefPubMed Pitt HA, Nakeeb A. Operative approach to gallbladder cancer. Curr Gastroenterol Rep. 2006;8:161–7.CrossRefPubMed
10.
Zurück zum Zitat de Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, Roa JC, Leon J, Maluenda F. Chemoradiotherapy in gallbladder cancer. J Surg Oncol. 2006;93:699–704.CrossRefPubMed de Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, Roa JC, Leon J, Maluenda F. Chemoradiotherapy in gallbladder cancer. J Surg Oncol. 2006;93:699–704.CrossRefPubMed
11.
Zurück zum Zitat Amano H, Takada T, Matsushiro, T Nimura Y, Nagakawa T, Nakayama T, Gomi K. Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreatic-biliary carcinomas. ASCO Meeting 1999. Amano H, Takada T, Matsushiro, T Nimura Y, Nagakawa T, Nakayama T, Gomi K. Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreatic-biliary carcinomas. ASCO Meeting 1999.
12.
Zurück zum Zitat Gallardo JO, Rubio B, Fodor M, Orlandi L, Yanez M, Gamargo C, Ahumada M. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol. 2001;12:1403–6.CrossRefPubMed Gallardo JO, Rubio B, Fodor M, Orlandi L, Yanez M, Gamargo C, Ahumada M. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol. 2001;12:1403–6.CrossRefPubMed
13.
Zurück zum Zitat Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, Awasthy BS. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90:1516–20.CrossRefPubMedPubMedCentral Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, Awasthy BS. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90:1516–20.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, Raina V, Shukla NK, Thulkar S, Garg P, Chaudhary SP. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. 28:4581–6. Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, Raina V, Shukla NK, Thulkar S, Garg P, Chaudhary SP. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. 28:4581–6.
15.
Zurück zum Zitat Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival and quality of life in pancreatic and biliary tract cancer. Ann Oncol. 1996;7:593–600.CrossRefPubMed Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival and quality of life in pancreatic and biliary tract cancer. Ann Oncol. 1996;7:593–600.CrossRefPubMed
16.
Zurück zum Zitat Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188–93.CrossRefPubMed Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188–93.CrossRefPubMed
17.
Zurück zum Zitat Randi G, Franceschi S, La VC. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591.CrossRefPubMed Randi G, Franceschi S, La VC. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591.CrossRefPubMed
18.
Zurück zum Zitat Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980;65:1209–14.PubMed Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980;65:1209–14.PubMed
20.
Zurück zum Zitat Principe A, Del Gaudio M, Ercoloni G, Golfieri R, Cucchetti A, Pinna AD. Radical surgery for gallbladder carcinoma: possibilities of survival. Hepato-Gastroenterology. 2006;53(71):660–4.PubMed Principe A, Del Gaudio M, Ercoloni G, Golfieri R, Cucchetti A, Pinna AD. Radical surgery for gallbladder carcinoma: possibilities of survival. Hepato-Gastroenterology. 2006;53(71):660–4.PubMed
21.
Zurück zum Zitat Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81.CrossRefPubMed Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81.CrossRefPubMed
22.
Zurück zum Zitat Pandey M, Shukla VK. Diet and gallbladder cancer: a case-control study. Eur J Cancer Prev. 2002;11:365–8.CrossRefPubMed Pandey M, Shukla VK. Diet and gallbladder cancer: a case-control study. Eur J Cancer Prev. 2002;11:365–8.CrossRefPubMed
23.
Zurück zum Zitat Moerman CJ, Bueno de Mesquita HB, Smeets FW, Runia S. Lifestyle factors including diet and cancer of the gallbladder and bile duct: a population-based case-control study in The Netherlands. Eur J Cancer Prev. 1997;6:139–42.PubMed Moerman CJ, Bueno de Mesquita HB, Smeets FW, Runia S. Lifestyle factors including diet and cancer of the gallbladder and bile duct: a population-based case-control study in The Netherlands. Eur J Cancer Prev. 1997;6:139–42.PubMed
24.
Zurück zum Zitat Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg. 2004;8:83–9. discussion 89CrossRefPubMed Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg. 2004;8:83–9. discussion 89CrossRefPubMed
25.
Zurück zum Zitat Zhang BH, Yi B, Peng LH, Zhang BH, Jiang XQ, Wu MC. The relationship between surgery and prognosis of gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(4):581–6.PubMed Zhang BH, Yi B, Peng LH, Zhang BH, Jiang XQ, Wu MC. The relationship between surgery and prognosis of gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(4):581–6.PubMed
26.
Zurück zum Zitat DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.CrossRefPubMed DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.CrossRefPubMed
27.
Zurück zum Zitat Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: to treat or not to treat? World J Gastroenterol. 2012 June 7;18(21):2591–6.CrossRefPubMedPubMedCentral Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: to treat or not to treat? World J Gastroenterol. 2012 June 7;18(21):2591–6.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2009;75:150–5.CrossRefPubMed Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2009;75:150–5.CrossRefPubMed
29.
Zurück zum Zitat Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 2002;54:414–9.CrossRefPubMed Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 2002;54:414–9.CrossRefPubMed
30.
Zurück zum Zitat Park HS, Lim JY, Yoon DS, Park JS, Lee DK, Lee SJ, et al. Outcome of adjuvant therapy for gallbladder cancer. Oncology. 2010;79:168–73.CrossRefPubMed Park HS, Lim JY, Yoon DS, Park JS, Lee DK, Lee SJ, et al. Outcome of adjuvant therapy for gallbladder cancer. Oncology. 2010;79:168–73.CrossRefPubMed
32.
Zurück zum Zitat Todoroki T, Takahashi H, Koike N, et al. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival. Hepato-Gastroenterology. 1999;46:2114–21.PubMed Todoroki T, Takahashi H, Koike N, et al. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival. Hepato-Gastroenterology. 1999;46:2114–21.PubMed
33.
Zurück zum Zitat Meng H, Wang X, Fong Y, Wang Z-H, Yu W, Zhang Z-T. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992–8.CrossRefPubMed Meng H, Wang X, Fong Y, Wang Z-H, Yu W, Zhang Z-T. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992–8.CrossRefPubMed
Metadaten
Titel
Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre
verfasst von
Santosh Kumar Singh
Rajnish Talwar
Narayanan Kannan
Arvind Kumar Tyagi
Pradeep Jaiswal
Adarsh Kumar
Publikationsdatum
03.04.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2018
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-017-9940-y

Weitere Artikel der Ausgabe 3/2018

Journal of Gastrointestinal Cancer 3/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.